Home » LUNDBECK CUTS 2006 TARGET DUE TO SLOWER US SALES
LUNDBECK CUTS 2006 TARGET DUE TO SLOWER US SALES
Danish pharmaceutical group Lundbeck on Tuesday cut its 2006 financial targets
due slower sales of its antidepressant drug Lexapro by its U.S. partner Forest
Labs. Lundbeck said Forest Labs had decided to cut its inventories of the drug
as a consequence of the slower market.
Reuters
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
07May
-
14May
-
30May